Company Filing History:

24 out of 677

Eisai Company, Limited

patents

1 out of 528

Eisai R&d Management Co., Ltd.

patents

Years Active: 1989-2007

Loading Chart...

25 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7304083 - 2-iminoimidazole derivatives (2) (2007-12-04),

2. 7244730 - 2-iminopyrrolidine derivatives (2007-07-17),

3. 6518423 - Benzopiperidine derivatives (2003-02-11),

4. 5482937 - 1,4-diazepine derivative and its pharmaceutical use (1996-01-09),

5. 5476864 - Glycerin derivative and its pharmacological use (1995-12-19),

6. 5476863 - Glycerin derivative and its pharmacological use (1995-12-19),

7. 5468740 - 1,4-diazepine derivative and its pharmaceutical use (1995-11-21),

8. 5438045 - 1,4-diazepine derivative and its pharmaceutical use (1995-08-01),

9. 5409909 - 1,4-diazepine derivative and its pharmaceutical use (1995-04-25),

10. 5382579 - Triazolo-1,4-diazepine derivatives and their use in pharmaceuticals (1995-01-17),

11. 5319139 - Naphthalene derivatives (1994-06-07),

12. 5304553 - 1,4-diazepine derivative and its pharmaceutical use (1994-04-19),

13. 5273985 - Glycerin derivative and its pharmacological use (1993-12-28),

14. 5262565 - Naphthalene derivatives (1993-11-16),

15. 5237091 - Naphthalene derivatives (1993-08-17),

Title: Kazuo Okano: Pioneering Innovator in Pharmaceutical Chemistry

Introduction:

Kazuo Okano, a prolific inventor in the field of pharmaceutical chemistry, hails from Ibaraki, Japan. With an impressive portfolio of 25 patents to his name, Okano has made significant contributions to the development of novel chemical compounds with therapeutic potential.

Latest Patents:

Among his latest patents are groundbreaking inventions in the realm of pharmaceuticals, including 2-iminoimidazole derivatives and 2-iminopyrrolidine derivatives. These derivatives exhibit unique structural compositions and have the potential to revolutionize drug discovery and development processes in the pharmaceutical industry.

Career Highlights:

Okano has garnered extensive experience working with renowned companies such as Eisai Company, Limited and Eisai R&D Management Co., Ltd. His tenure at these esteemed organizations has provided him with a platform to translate his innovative ideas into tangible inventions that have the power to impact the healthcare landscape significantly.

Collaborations:

Throughout his career, Okano has collaborated with esteemed professionals in the field, including distinguished colleagues like Shinya Abe and Hiroyuki Yoshimura. These collaborations have not only enriched his research endeavors but have also fostered a culture of knowledge exchange and innovation within the pharmaceutical industry.

Conclusion:

In conclusion, Kazuo Okano stands as a trailblazing inventor whose relentless pursuit of scientific excellence has led to the creation of groundbreaking pharmaceutical compounds. His ingenuity, coupled with his collaborative spirit, underscores his commitment to driving innovation in the field of pharmaceutical chemistry. Okano's patents serve as a testament to his invaluable contributions to the realm of drug discovery, with promising implications for the future of healthcare and therapeutics.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com